Ab Biotics S.A sell "i3.1®"

i3.1 Targeted IBS Relief Probiotic offers a clinically proven approach to managing irritable bowel syndrome (IBS), combining three strains, Pediococcus acidilactici KABP 021, Lactobacillus plantarum KABP 022 and Lactobacillus plantarum KABP 023, to support digestion, ease stress-related digestive issues and improve intestinal transit. Delivering 3 billion CFU per dose, it is recognized by the World Gastroenterology Organisation as an effective option for managing IBS and related gastrointestinal discomfort.